Does APREPITANT Cause C-reactive protein abnormal? 344 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 344 reports of C-reactive protein abnormal have been filed in association with APREPITANT (CINVANTI). This represents 6.1% of all adverse event reports for APREPITANT.
344
Reports of C-reactive protein abnormal with APREPITANT
6.1%
of all APREPITANT reports
314
Deaths
335
Hospitalizations
How Dangerous Is C-reactive protein abnormal From APREPITANT?
Of the 344 reports, 314 (91.3%) resulted in death, 335 (97.4%) required hospitalization, and 332 (96.5%) were considered life-threatening.
Is C-reactive protein abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 344 reports have been filed with the FAERS database.
What Other Side Effects Does APREPITANT Cause?
Fatigue (955)
Pyrexia (913)
Dyspnoea (909)
Hypersensitivity (881)
Rash (789)
Alopecia (760)
Gastrointestinal disorder (722)
Pruritus (707)
Confusional state (696)
Glossodynia (696)
What Other Drugs Cause C-reactive protein abnormal?
METHOTREXATE (3,734)
ADALIMUMAB (3,629)
ETANERCEPT (3,592)
ABATACEPT (3,402)
LEFLUNOMIDE (3,279)
TOCILIZUMAB (3,259)
HYDROXYCHLOROQUINE (3,245)
SULFASALAZINE (2,823)
INFLIXIMAB (2,676)
RITUXIMAB (2,608)
Which APREPITANT Alternatives Have Lower C-reactive protein abnormal Risk?
APREPITANT vs APROTININ
APREPITANT vs ARANESP
APREPITANT vs ARAVA
APREPITANT vs AREDIA
APREPITANT vs ARFORMOTEROL